The Multiple Myeloma Research Foundation advances the development of multiple myeloma treatments. Learn about multiple myeloma, MMRF research programs at themmrf.org
Find disease education and helpful resources for patients with Multiple Myeloma and their caregivers at Myeloma Central; brought to you by Celgene Corporation.
Information on a prescription medicine used to treat people with multiple myeloma who have received at least two prior medicines to treat multiple myeloma Important Safety Information WARNING: EMBRYO-FETAL TOXICITY and VENOUS THROMBOEMBOLISM Embryo-Fetal
Information on a prescription medicine used to treat people with multiple myeloma who have received at least two prior medicines to treat multiple myeloma Important Safety Information WARNING: EMBRYO-FETAL TOXICITY and VENOUS THROMBOEMBOLISM Embryo-Fetal
Get free authoritative information on bone metastases, myeloma bone disease, osteonecrosis of the jaw (ONJ), prostate cancer that spreads to bone, breast cancer that spreads to bone, and more.
3rd Annual Margaritas 4 Myeloma is at Dunwoody Tavern Nov 5, 2011 from 8-11pm! Drink specials, raffles, giveaways! All proceeds benefit the Multiple Myeloma Research Foundation.
About REVLIMID® (lenalidomide) treatment for deletion 5q myelodysplastic syndromes, mantle cell lymphoma and multiple myeloma including full indications, dosing, administration, efficacy, safety & prescribing information. Important Safety Information
About REVLIMID® (lenalidomide) treatment for deletion 5q myelodysplastic syndromes, mantle cell lymphoma and multiple myeloma including full indications, dosing, administration, efficacy, safety & prescribing information. Important Safety Information
About REVLIMID® (lenalidomide) treatment for deletion 5q myelodysplastic syndromes, mantle cell lymphoma and multiple myeloma including full indications, dosing, administration, efficacy, safety & prescribing information. Important Safety Information
Information on a prescription medicine used to treat people with multiple myeloma who have received at least two prior medicines to treat multiple myeloma Important Safety Information WARNING: EMBRYO-FETAL TOXICITY and VENOUS THROMBOEMBOLISM Embryo-Fetal
Information on a prescription medicine used to treat people with multiple myeloma who have received at least two prior medicines to treat multiple myeloma Important Safety Information WARNING: EMBRYO-FETAL TOXICITY and VENOUS THROMBOEMBOLISM Embryo-Fetal
About REVLIMID® (lenalidomide) treatment for deletion 5q myelodysplastic syndromes, mantle cell lymphoma and multiple myeloma including full indications, dosing, administration, efficacy, safety & prescribing information. Important Safety Information
'Are you newly diagnosed with multiple myeloma (MM) and have not been treated before for this condition? Check here for details and eligibility requirements.'
Information on a prescription medicine used to treat people with multiple myeloma who have received at least two prior medicines to treat multiple myeloma Important Safety Information WARNING: EMBRYO-FETAL TOXICITY and VENOUS THROMBOEMBOLISM Embryo-Fetal
myeloma.info is your first and best source for information about Myeloma . Here you will also find topics relating to issues of general interest. We hope you find what you are looking for!